| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible) |
- |
- |
1 － ? |
Cefotiam  |
1398 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible) |
- |
- |
1 － ? |
LBM415 (NVP-PDF-713, VIC-10495) |
624 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible) |
- |
- |
1 － ? |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
624 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
1398 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
624 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible) |
- |
- |
2 － ? |
Ampicillin (Omnipen) |
1398 |
| Staphylococcus aureus (ATCC 29213 + methicillin-susceptible) |
- |
- |
2 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
624 |
| Staphylococcus aureus (ATCC 29213 + powder 4oC) |
- |
- |
0.12 － ? |
Tigecycline (GAR-936, Tigacyl) |
322 |
| Staphylococcus aureus (ATCC 29213 + powder RT) |
- |
- |
0.06 － 0.12 |
Tigecycline (GAR-936, Tigacyl) |
322 |
| Staphylococcus aureus (ATCC 29213 + RT) |
- |
- |
0.25 － ? |
Tigecycline (GAR-936, Tigacyl) |
322 |
| Staphylococcus aureus (ATCC 29213 + second-step mutations) |
- |
- |
32 － ? |
REP8839 |
789 |
| Staphylococcus aureus (ATCC 29213 + second-step mutations) |
- |
- |
32 － ? |
REP8839 |
789 |
| Staphylococcus aureus (ATCC 29213 + second-step mutations) |
- |
- |
32 － ? |
REP8839 |
789 |
| Staphylococcus aureus (ATCC 29213 + serial passage) |
- |
- |
4 － ? |
REP8839 |
789 |
| Staphylococcus aureus (ATCC 29213 + serial passage) |
- |
- |
4 － ? |
REP8839 |
789 |
| Staphylococcus aureus (ATCC 29213 + serial passage) |
- |
- |
4 － ? |
REP8839 |
789 |
| Staphylococcus aureus (ATCC 29213 + serial passage) |
- |
- |
8 － 16 |
REP8839 |
789 |
| Staphylococcus aureus (ATCC 29213 + spontaneous resistance) |
- |
- |
0.5 － 1 |
REP8839 |
789 |
| Staphylococcus aureus (ATCC 29213 + spontaneous resistance) |
- |
- |
4 － 8 |
REP8839 |
789 |
| Staphylococcus aureus (ATCC 29213 + spontaneous resistance) |
- |
- |
16 － 32 |
REP8839 |
789 |
| Staphylococcus aureus (ATCC 29213) |
<0.1 |
<0.1 |
<0.1 － ? |
Tetracycline (Sumycin, Achromycin V, Steclin) |
190 |
| Staphylococcus aureus (ATCC 29213) |
- |
2 |
? － ? |
Benzalkonium chloride |
1524 |
| Staphylococcus aureus (ATCC 29213) |
- |
- |
0.004 － ? |
ACH-702 |
1279 |
| Staphylococcus aureus (ATCC 29213) |
- |
- |
0.004 － ? |
Rifampicin (Rifampin) |
401 |
| Staphylococcus aureus (ATCC 29213) |
- |
- |
0.015 － ? |
Imipenem |
401 |
| Staphylococcus aureus (ATCC 29213) |
- |
- |
0.015 － ? |
PD 124816 |
248 |
| Staphylococcus aureus (ATCC 29213) |
- |
- |
>0.015 － ? |
Rifampicin (Rifampin) |
299 |
| Staphylococcus aureus (ATCC 29213) |
- |
- |
0.03 － ? |
Clinafloxacin (PD 127391) |
248 |